Fig. 4
From: Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Sorafenib does not promote pDCs death. A PDCs (3 × 104) were pretreated with sorafenib (1 and 3 μg/mL) or DMSO (control) for 2 h, prior to stimulation with CpG-A (2.5 μM) for 24 h. The viability (A) and number (B) of pDCs were determined through a Guava Via count (Luminex). The pDCs from Fig. 3.D in these experiments, and the bars represent the mean ± S.D